Share this Article
Rastogi A, Bhadada SK, Bhansali A
Correpondence: Dr Sanjay Kumar Bhadada, bhadadask@rediffmail.com
ABSTRACT
A young woman with severe vitamin D deficiency presented with proximal muscle weakness, fragility fracture and pseudoarthrosis. On evaluation, she was found to have hypercalcaemia, a single parathyroid adenoma and an undetectable 25-hydroxyvitamin D level. She received parenteral cholecalciferol and subsequently underwent curative parathyroidectomy. Postoperatively, she had hungry bone syndrome, which she gradually recovered from with calcium and calcitriol replacement. Notably, her calcium levels were in the lower limit of normal range and associated with elevated alkaline phosphatase levels at postoperative Day 14. Follow-up for the next four years showed that the patient had remarkable symptomatic and radiological improvements. In this report, we discuss the pathophysiological interactions between vitamin D deficiency and associated primary hyperparathyroidism.
Keywords: pseudoarthrosis, primary hyperparathyroidism, vitamin D deficiency
Singapore Med J 2013; 54(11): e224-e227; http://dx.doi.org/10.11622/smedj.2013093
REFERENCES
| 1. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 1995; 43:351-8. http://dx.doi.org/10.1111/j.1365-2265.1995.tb02043.x | ||||
| 2. Shah VN, Bhadada SK, Bhansali A, et al. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 2012; 58:107-11. | ||||
| 3. Fouda MA. Primary hyperparathyroidism and vitamin D deficiency: A combination still encountered in Asian countries. Ann Saudi Med 1999; 19:455- 8. | ||||
| 4. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30. http://dx.doi.org/10.1210/jc.2011-0385 | ||||
| 5. Wermers RA, Khosla S, Atkinson EJ, et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997; 126:433-40. http://dx.doi.org/10.7326/0003-4819-126-6-199703150-00003 | ||||
| 6. Moosgaard B, Vestergaard P, Heickendorff L, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005; 63:506-13. http://dx.doi.org/10.1111/j.1365-2265.2005.02371.x | ||||
| 7. Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 2006; 29:511-5. | ||||
| 8. Kandil E, Tufaro AP, Carson KA, et al. Correlation of plasma 25- hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sistamibi scan. Arch Otolaryngol Head Neck Surg 2008; 134:1071-5. http://dx.doi.org/10.1001/archotol.134.10.1071 | ||||
| 9. Nordenström E, Westerdahl J, Lindergård B, Lindblom P, Bergenfelz A. Multifactorial risk for bone fractures in primary hyperparathyroidism. World J Surg 2002; 26:1463-7. http://dx.doi.org/10.1007/s00268-002-6433-2 | ||||
| 10. Ludwig GD, Kyle GC, de Blanco M. "Tertiary" hyperparathyroidism induced by osteomalacia resulting from phosphorus depletion. Am J Med 1967; 43:136-40. http://dx.doi.org/10.1016/0002-9343(67)90155-6 | ||||
| 11. Davies M, Heys SE, Selby PL, Berry JL, Mawer EB. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25- dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 1997; 82:209-12. http://dx.doi.org/10.1210/jc.82.1.209 | ||||
| 12. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005; 90:1525-30. http://dx.doi.org/10.1210/jc.2004-1891 | ||||
| 13. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:340-50. http://dx.doi.org/10.1210/jc.2008-1758 | ||||
| 14. Mikhail N. Clinical significance of vitamin D deficiency in primary hyperparathyroidism and safety of Vitamin D therapy. Southern Med J 2011; 104:29-33. http://dx.doi.org/10.1097/SMJ.0b013e3181fcd772 | ||||
| 15. Grubbs EG, Rafeeq S, Jimenez C, et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 2008; 144:852-8. http://dx.doi.org/10.1016/j.surg.2008.06.032 | ||||